Background
Michelle Rudek, Pharm.D., Ph.D., is a Professor of oncology at the Johns Hopkins University School of Medicine and director of the Analytical Pharmacology Core for the Johns Hopkins Kimmel Cancer Center.
Dr. Rudek studies the pharmacokinetic-pharmacodynamic properties of anticancer agents, and her research is focused on oncology (preclinical studies and Phase I clinical trials/early phase drug development) and special populations within oncology (AIDS malignancy, and organ dysfunction).
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.